Found: 22
Select item for more details and to access through your institution.
Environmentally Persistent Free Radicals Cause Apoptosis in HL-1 Cardiomyocytes.
- Published in:
- Cardiovascular Toxicology, 2017, v. 17, n. 2, p. 140, doi. 10.1007/s12012-016-9367-x
- By:
- Publication type:
- Article
Active and Passive Immunization with an Anti-Methamphetamine Vaccine Attenuates the Behavioral and Cardiovascular Effects of Methamphetamine.
- Published in:
- Vaccines, 2022, v. 10, n. 9, p. 1508, doi. 10.3390/vaccines10091508
- By:
- Publication type:
- Article
ACE2-Mediated Reduction of Oxidative Stress in the Central Nervous System Is Associated with Improvement of Autonomic Function.
- Published in:
- PLoS ONE, 2011, v. 6, n. 7, p. 1, doi. 10.1371/journal.pone.0022682
- By:
- Publication type:
- Article
Protective Effects of PARP-1 Knockout on Dyslipidemia- Induced Autonomic and Vascular Dysfunction in ApoE<sup>-/-</sup> Mice: Effects on eNOS and Oxidative Stress.
- Published in:
- PLoS ONE, 2009, v. 4, n. 10, p. 1, doi. 10.1371/journal.pone.0007430
- By:
- Publication type:
- Article
364 Beneficial Actions of SGLT2 Inhibition and H2S Therapy in Heart Failure with Preserved Ejection Fraction.
- Published in:
- 2023
- By:
- Publication type:
- Abstract
Epigenetic mechanisms differentially regulate blood pressure and renal dysfunction in male and female Npr1 haplotype mice.
- Published in:
- FASEB Journal, 2024, v. 38, n. 15, p. 1, doi. 10.1096/fj.202400714R
- By:
- Publication type:
- Article
H<sub>2</sub>S Therapy Improves Diastolic Dysfunction and Exercise Capacity in Two‐Hit Murine Model of Heart Failure with Preserved Ejection Fraction.
- Published in:
- FASEB Journal, 2022, v. 36, p. N.PAG, doi. 10.1096/fasebj.2022.36.S1.R4073
- By:
- Publication type:
- Article
Role of S‐nitrosoglutathione reductase (GSNOR) Dysregulation and Nitrosative Stress in Heart Failure With Preserved Ejection Fraction.
- Published in:
- FASEB Journal, 2022, v. 36, p. N.PAG, doi. 10.1096/fasebj.2022.36.S1.R2460
- By:
- Publication type:
- Article
Regulation of Blood Pressure and Renal Fibrosis by Class I Specific HDAC Inhibitor, Mocetinostat, in Npr1 Gene‐targeted Male and Female Mice.
- Published in:
- FASEB Journal, 2021, v. 35, p. N.PAG, doi. 10.1096/fasebj.2021.35.S1.03773
- By:
- Publication type:
- Article
A Novel Mouse Model of Cardiometabolic Heart Failure with Preserved Ejection Fraction.
- Published in:
- FASEB Journal, 2021, v. 35, p. N.PAG, doi. 10.1096/fasebj.2021.35.S1.05427
- By:
- Publication type:
- Article
Renal Denervation Improves Exercise Performance in the Setting of Severe Cardiometabolic HFpEF.
- Published in:
- FASEB Journal, 2021, v. 35, p. N.PAG, doi. 10.1096/fasebj.2021.35.S1.05239
- By:
- Publication type:
- Article
Brain ACE2 overexpression reduces DOCA‐salt hypertension independently of endoplasmic reticulum stress (875.3).
- Published in:
- FASEB Journal, 2014, v. 28, p. N.PAG, doi. 10.1096/fasebj.28.1_supplement.875.3
- By:
- Publication type:
- Article
Brain ACE2 overexpression stimulates food intake and promotes glucose intolerance in mice (1126.15).
- Published in:
- FASEB Journal, 2014, v. 28, p. N.PAG, doi. 10.1096/fasebj.28.1_supplement.1126.15
- By:
- Publication type:
- Article
Angiotensin‐II mediates ACE2 internalization and degradation through an angiotensin‐II type I receptor‐dependent mechanism (1066.9).
- Published in:
- FASEB Journal, 2014, v. 28, p. N.PAG, doi. 10.1096/fasebj.28.1_supplement.1066.9
- By:
- Publication type:
- Article
Combination Sodium Nitrite and Hydralazine Therapy Attenuates Heart Failure With Preserved Ejection Fraction Severity in a "2-Hit" Murine Model.
- Published in:
- Journal of the American Heart Association, 2023, v. 12, n. 4, p. 1, doi. 10.1161/JAHA.122.028480
- By:
- Publication type:
- Article
Endothelial Cell Cystathionine γ-Lyase Expression Level Modulates Exercise Capacity, Vascular Function, and Myocardial Ischemia Reperfusion Injury.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Adjunctive therapy with an oral H<sub>2</sub>S donor provides additional therapeutic benefit beyond SGLT2 inhibition in cardiometabolic heart failure with preserved ejection fraction.
- Published in:
- British Journal of Pharmacology, 2024, v. 181, n. 21, p. 4294, doi. 10.1111/bph.16493
- By:
- Publication type:
- Article
Angiotensin-Converting Enzyme 2: Central Regulator for Cardiovascular Function.
- Published in:
- Current Hypertension Reports, 2010, v. 12, n. 3, p. 170, doi. 10.1007/s11906-010-0105-7
- By:
- Publication type:
- Article
Angiotensin-converting enzyme 2: a new target for neurogenic hypertension.
- Published in:
- 2010
- By:
- Publication type:
- Report
Angiotensin-converting enzyme 2 in the brain: properties and future directions.
- Published in:
- Journal of Neurochemistry, 2008, v. 107, n. 6, p. 1482, doi. 10.1111/j.1471-4159.2008.05723.x
- By:
- Publication type:
- Article
Angiotensin I-converting enzyme type 2 (ACE2) gene therapy improves glycemic control in diabetic mice.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Angiotensin I--Converting Enzyme Type 2 (ACE2) Gene Therapy Improves Glycemic Control in Diabetic Mice.
- Published in:
- Diabetes, 2010, v. 59, n. 10, p. 2540, doi. 10.2337/db09-0782
- By:
- Publication type:
- Article